Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 336 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

336 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 336 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

336 programs

Clinical programs

Page 4 of 7

  1. Ipilimumab

    United Therapeutics Europe Ltd

    BCLC Stage B Hepatocellular Carcinoma

    phase 2 mab terminated

    1 trial

  2. Irosustat

    United Therapeutics Europe Ltd

    Breast Neoplasms

    phase 2 small molecule terminated

    1 trial

  3. Isosorbide Mononitrate

    United Therapeutics Europe Ltd

    Kidney Injury

    phase 2 small molecule terminated

    1 trial

  4. L-citrulline

    United Therapeutics Europe Ltd

    Post Deployment Related Asthma

    phase 2 small molecule active

    1 trial

  5. Lactezin

    United Therapeutics Europe Ltd

    Hormonal Acne

    phase 2 other active

    1 trial

  6. Lapatinib

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  7. Lenalidomide

    United Therapeutics Europe Ltd

    Recurrent Mantle Cell Lymphoma

    phase 2 small molecule active

    1 trial

  8. Lenvatinib

    United Therapeutics Europe Ltd

    Columnar Cell Variant Thyroid Gland Papillary Carcinoma

    phase 2 small molecule completed

    1 trial

  9. Letrozole

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  10. Letrozole

    United Therapeutics Europe Ltd

    Lymphangioleiomyomatosis

    phase 2 small molecule completed

    1 trial

  11. Leukocyte-Poor Platelet Rich Plasma (LP-PRP)

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    phase 2 mab active

    1 trial

  12. Levoleucovorin Calcium

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 2 small molecule active

    1 trial

  13. Liposomal Bupivacaine

    United Therapeutics Europe Ltd

    Femoral Fractures

    phase 2 small molecule terminated

    1 trial

  14. Liposomal Irinotecan

    United Therapeutics Europe Ltd

    Oncology

    phase 2 small molecule completed

    1 trial

  15. Liposomal bupivacaine

    United Therapeutics Europe Ltd

    Blunt Chest Wall Trauma

    phase 2 small molecule completed

    1 trial

  16. Lofexidine

    United Therapeutics Europe Ltd

    Post Traumatic Stress Disorder

    phase 2 small molecule completed

    1 trial

  17. Losartan

    United Therapeutics Europe Ltd

    Hip Osteoarthritis

    phase 2 small molecule terminated

    1 trial

  18. Losmapimod

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule completed

    1 trial

  19. Lovaza, omega-3 fatty acid ethyl ester

    United Therapeutics Europe Ltd

    Mood Disorders

    phase 2 small molecule active

    1 trial

  20. MAb-3F8

    United Therapeutics Europe Ltd

    Primary Refractory Neuroblastoma

    phase 2 mab terminated

    1 trial

  21. MVA85A

    United Therapeutics Europe Ltd

    Tuberculosis

    phase 2 mab completed

    1 trial

  22. Magnesium Sulfate

    United Therapeutics Europe Ltd

    Traumatic Brain Injury

    phase 2 small molecule terminated

    1 trial

  23. Mesenchymal Stromal Cells

    United Therapeutics Europe Ltd

    Corneal Ulcer

    phase 2 mab active

    1 trial

  24. Metformin

    United Therapeutics Europe Ltd

    Polycystic Kidney, Autosomal Dominant

    phase 2 small molecule completed

    1 trial

  25. Metformin

    United Therapeutics Europe Ltd

    C9orf72 Amyotrophic Lateral Sclerosis (ALS)

    phase 2 small molecule active

    1 trial

  26. Metformin + Standard of Care

    United Therapeutics Europe Ltd

    Focal Segmental Glomerulosclerosis

    phase 2 small molecule active

    1 trial

  27. Micronized DHACM 40 mg

    United Therapeutics Europe Ltd

    Knee Osteoarthritis

    phase 2 mab terminated

    1 trial

  28. Midazolam

    United Therapeutics Europe Ltd

    Stress Disorders, Post-Traumatic

    phase 2 small molecule completed

    1 trial

  29. Mind-Body Bridging Program

    United Therapeutics Europe Ltd

    Sleep Disturbance

    phase 2 other completed

    1 trial

  30. Minocycline Hydrochloride

    United Therapeutics Europe Ltd

    Acute Pain

    phase 2 small molecule completed

    1 trial

  31. Mitomycin C

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 2 small molecule active

    1 trial

  32. Modafinil 200mg

    United Therapeutics Europe Ltd

    Cognition

    phase 2 small molecule active

    1 trial

  33. Modified-Release Prednisone

    United Therapeutics Europe Ltd

    Chronic Inflammation

    phase 2 small molecule completed

    1 trial

  34. Multi-epitope HER2 Peptide Vaccine TPIV100

    United Therapeutics Europe Ltd

    Breast Adenocarcinoma

    phase 2 mab active

    1 trial

  35. MultiStem

    United Therapeutics Europe Ltd

    Trauma

    phase 2 mab active

    1 trial

  36. N-Acetyl cysteine

    United Therapeutics Europe Ltd

    Neurofibromatosis 1

    phase 2 small molecule active

    1 trial

  37. N-acetyl cysteine

    United Therapeutics Europe Ltd

    Multiple Sclerosis

    phase 2 small molecule active

    1 trial

  38. N-acetylcysteine

    United Therapeutics Europe Ltd

    Posttraumatic Stress Disorder (PTSD)

    phase 2 small molecule completed

    1 trial

  39. N-acetylcysteine capsule

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 2 small molecule completed

    1 trial

  40. NTX-001

    United Therapeutics Europe Ltd

    Peripheral Nerve Injuries

    phase 2 small molecule active

    1 trial

  41. NanoDOX Hydrogel

    United Therapeutics Europe Ltd

    Orthopedic Trauma Wounds

    phase 2 small molecule terminated

    1 trial

  42. Nasal Carbon Dioxide

    United Therapeutics Europe Ltd

    Migraine

    phase 2 small molecule terminated

    1 trial

  43. Nivolumab

    United Therapeutics Europe Ltd

    Metastatic Uveal Melanoma

    phase 2 small molecule completed

    1 trial

  44. Non-invasive ventilation

    United Therapeutics Europe Ltd

    Amyotrophic Lateral Sclerosis (ALS)

    phase 2 other active

    1 trial

  45. OGX-011

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 mab completed

    1 trial

  46. Octreotide Acetate

    United Therapeutics Europe Ltd

    Liver Transplantation

    phase 2 small molecule active

    1 trial

  47. Olaparib

    United Therapeutics Europe Ltd

    Bile Duct Adenocarcinoma

    phase 2 small molecule active

    1 trial

  48. Oral treprostinil

    United Therapeutics Europe Ltd

    Systemic Sclerosis

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

336 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.